Iceland vs South-Eastern Asia: Proportion of the target population who received
Iceland
98.0%
in 2024
South-Eastern Asia
81.0%
in 2024
Iceland rank
17th
South-Eastern Asia rank
16th
Proportion of the target population who received over time
- Iceland
- South-Eastern Asia
How they compare
Iceland currently reports 98.0% against 81.0% in South-Eastern Asia, a difference of 17.0%.
That makes Iceland's figure about 1.2 times South-Eastern Asia's.
The two have swapped places 2 times across 22 shared years of data; in 2003 it was Iceland ahead.
Iceland ranks 17th and South-Eastern Asia ranks 16th of 193 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iceland | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.3% | 36.3% | 56.0% | Iceland |
| 2010s | 93.9% | 67.7% | 26.2% | Iceland |
| 2020s | 74.0% | 71.8% | 2.2% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Iceland or South-Eastern Asia?
- Iceland, at 98.0% against 81.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received between Iceland and South-Eastern Asia?
- 17.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and South-Eastern Asia?
- 22 years are reported by both, from 2003 to 2024.
- How do Iceland and South-Eastern Asia rank globally for proportion of the target population who received?
- Iceland ranks 17th and South-Eastern Asia ranks 16th of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.